Gastroretentive microparticles for drug delivery applications

Journal of Microencapsulation

Volumn 28, Issue 8, 2011, Pages 689-708

  Adebisi, Adeola ^a   Conway, Barbara R ^a  

^a UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

Author keywords

Controlled release; Drug delivery; Gastroretentive system; Microspheres; Oral delivery

Indexed keywords

ALGINIC ACID; AMOXICILLIN; ANTACID AGENT; ANTIBIOTIC AGENT; BICARBONATE; CARBOMER; CHITOSAN; CLARITHROMYCIN; ETHYL CELLULOSE; LECTIN; METRONIDAZOLE; MICROSPHERE; OMEPRAZOLE; POLYMER; PROTON PUMP INHIBITOR;

AGE; AMINO ACID SEQUENCE; ANTIBIOTIC THERAPY; BODY POSTURE; DRUG ADSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; FOOD INTAKE; GENDER; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MICROENCAPSULATION; NONHUMAN; PATIENT COMPLIANCE; REVIEW; STOMACH; STOMACH EMPTYING;

ANIMALS; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; GASTROINTESTINAL TRACT; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PHARMACEUTICAL PREPARATIONS;

EID: 82255196197     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2011.590613     Document Type: Review

References (207)

1. Adebisi AO, Conway BR. Development of gastro-retentive systems for the eradication of H-pylori infections in the treatment of peptic ulcer. J Pharm Pharmacol, 2010;62:1201-516.
2. Ahmed MG, Satish KBP, Kiran KBP. Formulation and evaluation of gastric-mucoadhesive drug delivery systems of captopril. J Current Pharm Res, 2010;2:26-32.
3. Akbuga J. Use of chitosonium malate as a matrix in sustained-release tablets. Int J Pharm, 1993;89:19-24. (Pubitemid 23008587)
4. Akiyama Y, Nagahara N, Kashihara T, Hirai S, Toguchi H. In vitro and in vivo evaluation of mucoadhesive microspheres prepared for the gastrointestinal tract using polyglycerol esters of fatty acid esters of fatty acids and a poly(acrylic acid) derivatives. Pharm Res, 1995;12:397-405.
5. Anilkumar SJ. 2008. Gastro retentive drug delivery systems: An overview, 6. Online Available at: http://www.Pharminfo.net, Accessed 12 October 2010.
6. Annese V, Bassotti G, Napolitano G, Frusciante V, Bruno M, Conoscitore P, Germani U, Morelli A, Andriulli A. Gastric emptying of solids in patients with nonobstructive Crohn's disease is sometimes delayed. J Clin Gastroenterol, 1995;21:279-82.
7. Ashwell G, Harford J. Carbohydrate-specific receptors of the liver. Annu Rev Biochem, 1982;51:531-54.
8. Aspden TJ, Illum L, Skaugrud O. Chitosan as a nasal delivery system-evaluation of insulin absorption enhancement and effect on nasal membrane integrity using rat models. Eur J Pharm Sci, 1996;4:23-31. (Pubitemid 26016570)
9. Atyabi F, Sharma HL, Mohammad HAH, Fell JT. Controlled drug release from coated floating ion exchange resin beads. J Control Release, 1996a;42:25-8. (Pubitemid 26297872)
10. Atyabi F, Sharma HL, Mohammad HAH, Fell JT. In vivo evaluation of a novel gastric retentive formulation based on ion exchange resins. J Control Release, 1996b;42:105-13. (Pubitemid 26319849)
11. Batchelor HK, Conway BR, Williams RO, 2007. Targeting the infections within the gastro-intestinal tract. In: Williams RO III, Taft DR, McConville JT, editors. Advanced drug formulation design to optimize therapeutic outcomes (Drugs and the pharmaceutical sciences). New York: Informa Healthcare. pp 217-44.
12. Bechgaard H, Ladefoged K. Distribution of pellets in the gastrointestinal tract. The influence on transit time exerted by the density or diameter of pellets. J Pharm Pharmacol, 1978;30:690-2. (Pubitemid 9063329)
13. Benita S, Benoit JP, Puisieux F, Thies C. Characterization of drug-loaded poly(d,l-lactide) microspheres. J Pharm Sci, 1984;73:1721-4. (Pubitemid 15190922)
14. Bernkop-Schnürch A, Gabor F, Szostak MP, Lubitz W. An adhesive drug delivery system based on K99-fimbriae. Eur J Pharm Sci, 1995;3:293-9.
15. Bhaskara RS, Sharma CP. Use of chitosan as biomaterial: Studies on its safety and hemostatic potential. J Biomed Mater Res, 1997;34:21-8. (Pubitemid 26425214)
16. Bodmeier R, McGinity JW. Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique: I. Methods and morphology. J Microencapsul, 1987a;4:279-88. (Pubitemid 18043933)
17. Bodmeier R, McGinity JW. Polylactic acid microspheres containing quini-dine base and quinidine sulphate prepared by the solvent evaporation technique: II. Some process parameters influencing the preparation and properties of microspheres. J Microencapsul, 1987b;4:289-97. (Pubitemid 18043934)
18. Bowman WC, Rand MJ, West GB, 1968. Textbook of pharmacology. Oxford, Edinburgh: Blackwell Scientific.
19. Capan Y, Jiang G, Giovagnoli S, Na KH, Deluca PP. Preparation and characterization of poly(D,L-lactide-co-glycolide) microspheres for controlled release of human growth hormone. AAPS Pharm Sci Tech, 2003;4:E28.
20. Ch'ng HS, Park H, Kelly P, Robinson JR. Bioadhesive polymers as platforms for oral controlled drug delivery II: Synthesis and evaluation of some swelling, water-insoluble bioadhesive polymers. J Pharm Sci, 1985;74:399-405. (Pubitemid 15112929)
21. Chang FY, Lu CL, Chen CY, Luo JC, Jium KL, Lee SD. Effect of Helicobacter Pylori eradicated therapy on water gastric emptying in patients with active duodenal ulcer. J Gastroenterol Hepatol, 2003;18:1250-6. (Pubitemid 37463999)
22. Chary RB, Vani G, Rao YM. In vitro and in vivo adhesion testing of mucoad-hesive drug delivery systems. Drug Dev Ind Pharm, 1999;25:685-90. (Pubitemid 29186303)
23. Chawla G, Gupta P, Koradia V, Bansal AK. Gastroretention: A means to address regional variability in intestinal drug absorption. Pharma Technol, 2003;27:50-68. (Pubitemid 37101890)
24. Chickering DE, Jacob JS, Mathiowitz E. Bioadhesive microspheres, II: Characterization and evaluation of bioadhesion involving hard, bioer-odible polymers and soft tissue. Reactive Polymers, 1995;25:189-206.
25. Chitnis VS, Malshe VS, Lalla JK. Bioadhesive polymers synthesis, evaluation and application in controlled release tablets. Drug Dev Ind Pharm, 1991;17:879-92.
26. Chowdary KP, Rao YS. Design and in vitro and in vivo evaluation of mucoadhesive microcapsules of glipizide for oral controlled release: A technical note. AAPS Pharm Sci Tech, 2003;4:E39.
27. Chowdary KP, Rao YS. Mucoadhesive microspheres for controlled drug delivery. Biol Pharm Bull, 2004;27:1717-24. (Pubitemid 41701593)
28. Chun MK, Cho CS, Choi HK. Mucoadhesive microspheres prepared by interpolymer complexation and solvent diffusion method. Int J Pharm, 2005a;288:295-303.
29. Chun MK, Sah H, Choi HK. Preparation of mucoadhesive microspheres containing antimicrobial agents for eradication of H. pylori. Int J Pharm, 2005b;297:172-9. (Pubitemid 40720277)
30. Clarke GM, Newton JM, Short MD. Gastrointestinal transit of pellets of differing size and density. Int J Pharm, 1993;100:81-92. (Pubitemid 23316319)
31. Conway BR. Drug delivery strategies for the treatment of Helicobacter pylori infections. Curr Pharm Des, 2005;11:775-90. (Pubitemid 40347980)
32. Cuna M, Alonso MJ, Torres D. Preparation and in vivo evaluation of mucoadhesive microparticles containing amoxicillin-resin complexes for drug delivery to the gastric mucosa. Eur J Pharm Biopharm, 2001;51:199-205. (Pubitemid 32422096)
33. Daharwal SJ, Koner P, Saudagar RB. 2007. Gastro-retentive drugs: A novel approach towards floating therapy. Online Available at: http://www.pharmainfo. net 5. Accessed 27 September 2009.
34. Davis DW. 1968. Method of swallowing a pill. US patent application US Patent no. 3418999.
35. Davis SS. Formulation strategies for absorption windows. Drug Discov Today, 2005;10:249-57. (Pubitemid 40222218)
36. Davis SS, Stockwell AF, Taylor MJ, Hardy JG, Whalley DR, Wilson CG, Bechgaard H, Christensen FN. The effect of density on the gastric emptying of single-and multiple-unit dosage forms. Pharm Res, 1986;3:208-13. (Pubitemid 17195371)
37. Dennis A, Timmins P. 1992. Buoyant controlled release powder formulations. US patent application US Patent 5169638. December 8.
38. Desai JU. 2007. Floating drug delivery systems: An approach to gastroretention. Pharminfo.net, 5. Online Available at: http://www. pharmainfo.net/reviews/floating-drug-delivery-systemsan-approach-gastro- retention. Accessed 15 November 2010.
39. Deshpande AA, Rhodes CT, Shah NH, Malick AW. Controlled-release drug delivery systems for prolonged gastric residence: An overview. Drug Dev Ind Pharm, 1996;22:531-9. (Pubitemid 26197851)
40. Dhaliwal S, Jain S, Singh HP, Tiwary AK. Mucoadhesive microspheres for gastroretentive delivery of acyclovir: In vitro and in vivo evaluation. AAPS J, 2008;10:322-30.
41. El-Gibaly I. Development and in vitro evaluation of novel floating chitosan microcapsules for oral use: Comparison with non-floating chitosan microspheres. Int J Pharm, 2002;249:7-21. (Pubitemid 35333428)
42. Erni W, Held K. The hydrodynamically balanced system: A novel principle of controlled drug release. Eur Neurol, 1987;27 (1):21-7. (Pubitemid 17152034)
43. Fabregas JL, Claramunt J, Cucala J, Pous R, Siles A. "In-Vitro" testing of an antacid formulation with prolonged gastric residence time (Almagate Flot-Coat®). Drug Dev Ind Pharm, 1994;20:1199-212. (Pubitemid 24136493)
44. Fiebrig I, Harding SE, Rowe AJ, Hyman SC, Davis SS. Transmission electron microscopy studies on pig gastric mucin and its interactions with chitosan. Carbohydrate Polymers, 1995;28:239-44.
45. Fix JA, Cargill R, Engle K. Controlled gastric emptying: III. Gastric residence time of a nondisintegrating geometric shape in human volunteers. Pharm Res, 1993;10:1087-9. (Pubitemid 23211437)
46. Franz MR, Oth MP. 1992. Sustained release: Bilayer buoyant dosage form. US patent application US Patent 5232704. 3 August 1992.
47. Gaba P. 2008. Floating microspheres: A review. Pharminfo.net, 6. Online Available at: http://www.pharmainfo.net/reviews/floating-microspheres-review. Accessed 27 November 2010.
48. Gabor F, Wirth M, Jurkovich B, Haberl I, Theyer G, Walcher G, Hamilton G. Lectin-mediated bioadhesion: Pro teolytic stability and binding-characteristics of wheat germagglu tinin and Solanum tuberosumlectin on Caco-2, HT-29 and human colonocytes. J Control Release, 1997;49:27-37. (Pubitemid 27417898)
49. Gad SC, 2008. Pharmaceutical manufacturing handbook. In: Gad SC, editor. Production and processes. New York: Wiley Interscience.
50. Gao Y, Cui F, Guan Y, Yang L, Wang Y, Zhang L. Preparation of roxithromycin-polymeric microspheres by the emulsion solvent diffusion method for taste masking. Int J Pharm, 2006;318:62-9. (Pubitemid 43983049)
51. Garg R, Gupta GD. Progress in controlled gastroretentive delivery systems. Trop J Pharm Res, 2008;7:1055-66.
52. Garg R, Gupta GD. Gastroretentive floating microspheres of silymarin: Preparation and in vitro evaluation. Trop J Pharm Res, 2010;9:59-66.
53. Garg S, Sharma S. Gastroretentive drug delivery systems. Business Briefing. Pharmatech 2003:160-6. Online Available at: www.touchbriefings.com/ download.cfm?fileID=528. Accessed 15 November 2010.
54. Gaserød O, Jolliffe IG, Hampson FC, Dettmar PW, Skjak-bræk G. The enhancement of the bioadhesive properties of calcium alginate gel beads by coating with chitosan. Int J Pharm, 1998;175:237-46. (Pubitemid 28517980)
55. Gattani SG, Savaliya PJ, Belgamwar VS. Floating-mucoadhesive beads of clarithromycin for the treatment of Helicobacter pylori infection. Chem Pharm Bull (Tokyo), 2010;58:782-7.
56. Gibley IE. Development and in vitro evaluation of novel floating chitosan microcapsule for oral use: Comparison with nonfloating chitosan microspheres. Int J Pharm, 2002;249:7-21.
57. Gohel MC, Amin AF. Formulation optimization of controlled release diclofenac sodium microspheres using factorial design. J Control Release, 1998;51:115-22. (Pubitemid 28252862)
58. Grant GT, Morris ER, Rees DA, Smith PJC, Thom D. Biological interactions between polysaccharides and divalent cations: The egg-box model. FEBS Lett, 1973;32:195-8.
59. Gregoriadis G, Florence AT. Liposomes in drug delivery, Clinical, diagnostic and ophthalmic potential. Drugs, 1993;145:15-28. (Pubitemid 23093890)
60. Grill BB, Lange R, Markowitz R, Hillemeier AC, Mccallum RW, Gryboski JD. Delayed gastric emptying in children with Crohn's disease. J Clin Gastroenterol, 1985;7:216-26. (Pubitemid 15046281)
61. Groning R, Cloer C, Georgarakis M, Muller RS. Compressed collagen sponges as gastroretentive dosage forms: In vitro and in vivo studies. Eur J Pharm Sci, 2007;30:1-6. (Pubitemid 44908920)
62. Gröning R, Heun G. Oral dosage forms with controlled gastrointestinal transit. Drug Dev Ind Pharm, 1984;10:527-39. (Pubitemid 14122735)
63. Gruber P, Rubenstein A, Li VH, Bass P, Robinson JR. Gatric emptying of non-digestible solids in the fasted dog. J Pharm Sci, 1987;76:117-22.
64. Gu TH, Chen SX, Zhu JB, Song DJ, Guo JZ, HOU HM. Pharmacokinetics and pharmacodynamics of diltiazem floating tablets. Zhongguo Yao Li Xue Bao, 1992;13:527-31.
65. Gupta PK, Hung CT. Albumin microspheres: II. Applications in drug delivery. J Microencapsul, 1989;6:463-72. (Pubitemid 19278415)
66. Haas J, Lehr CM. Developments in the area of bioadhesive drug delivery systems. Expert Opin Biol Ther, 2002;2:287-98. (Pubitemid 34464810)
67. Harrigan RM. 1977. Drug delivery device for preventing contact of undis-solved drug with the stomach lining. United States patent application. 25 October 1977.
68. Hassan EE, Parish RC, Gallo JM. Optimized formulation of magnetic chit-osan microspheres containing the anticancer agent, oxantrazole. Pharm Res, 1992;9:390-7.
69. He P, Davis SS, Illum L. In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int J Pharm, 1998;166:75-88. (Pubitemid 28239741)
70. Henriksen I, Green KL, Smart JD, Smistad G, Karlsen J. Bioadhesion of hydrated chitosans: An in vitro and in vivo study. Int J Pharm, 1996;145:231-40. (Pubitemid 27063004)
71. Hirtz J. The gastrointestinal absorption of drugs in man: A review of current concepts and methods of investigation. Br J Clin Pharmacol, 1985;19:77S-83S. (Pubitemid 16193625)
72. Horowitz M, Wishart JM, Jones KL, Hebbard GS. Gastric emptying in diabetes: An overview. Diabet Med, 1996;13:S16-22.
73. Hou WM, Miyazaki S, Takada M, Komai T. Sustained release of indometha-cin from chitosan granules. Chem Pharm Bull (Tokyo), 1985;33:3986-92. (Pubitemid 16235658)
74. Huang K, Lee BP, Ingram DR, Messersmith PB. Synthesis and characterization of self-assembling block copolymers containing bioadhesive end groups. Biomacromolecules, 2002;3:397-406. (Pubitemid 34257162)
75. Hunt JN, 1968. Regulation of gastric emptying. In: Society AP, editor. Handbook of physiology. Washington, DC: American Physiology Society. pp 1917-35.
76. Hwang SJ, Park H, Park K. Gastric retentive drug-delivery systems. Crit Rev Ther Drug Carrier Syst, 1998;15:243-84. (Pubitemid 28366513)
77. Iannuccelli V, Coppi G, Bernabei MT, Cameroni R. Air compartment multiple-unit system for prolonged gastric residence. Part I. Formulation study. Int J Pharm, 1998;174:47-54. (Pubitemid 28486988)
78. Ichikawa M, Kato T, Kawahara M, Watanabe S, Kayano M. A new multiple-unit oral floating dosage system. II: In vivo evaluation of floating and sustained-release characteristics with p-aminobenzoic acid and isosor-bide dinitrate as model drugs. J Pharm Sci, 1991a;80:1153-6.
79. Ichikawa M, Watanabe S, Miyake Y. A new multiple-unit oral floating dosage system. I: Preparation and in vitro evaluation of floating and sustained-release characteristics. J Pharm Sci, 1991b;80:1062-6.
80. Iijima K, Sekine H, Koike T, Imatani A, Ohara S, Shimosegawa T. Long-term effect of Helicobacter-pylori eradication on the reversibility of acid secretion in profound hypochlorhydria. Aliment Pharmacol Ther, 2004;19:1181-8. (Pubitemid 38746261)
81. Ikeda K, Murata K, Kobayashi M, Noda K. Enhancement of bioavailability of dopamine via nasal route in beagle dogs. Chem Pharm Bull (Tokyo), 1992;40:2155-8.
82. Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm Res, 1998;15:1326-31. (Pubitemid 28427917)
83. Illum L, Faraj NF, Critchley H, Johansen BR, Davis SS. Enhanced nasal absorption of insulin in rats using lysophosphatidylcholine. Int J Pharm, 1989;57:49-54. (Pubitemid 20017863)
84. Illum L, Faraj NF, Davis SS. Chitosan as a novel nasal delivery system for peptide drugs. Pharm Res, 1994;11:1186-9. (Pubitemid 24259861)
85. Ishak RA, Awad GA, Mortada N, Nour SA. Preparation, in vitro and in vivo evaluation of stomach-specific metronidazole-loaded alginate beads as local anti-Helicobacter pylori therapy. J Control Release, 2007;119:207-14. (Pubitemid 46754505)
86. Jain SK, Agrawal GP, Jain N. Evaluation of porous carrier-based floating orlistat microspheres for gastric delivery. AAPS PharmSciTech, 2006a;7(4):E54-E62.
87. Jain SK, Agrawal GP, Jain NK. A novel calcium silicate based microspheres of repaglinide: In vivo investigations. J Control Release, 2006b;113:111-16. (Pubitemid 43928144)
88. Jain SK, Awasthi AM, Jain NK, Agrawal GP. Calcium silicate based micro-spheres of repaglinide for gastroretentive floating drug delivery: Preparation and in vitro characterization. J Control Release, 2005;107:300-9. (Pubitemid 41316292)
89. Jain SK, Jangdey MS. Lectin conjugated gastroretentive multiparticulate delivery system of clarithromycin for the effective treatment of Helicobacter pylori. Mol Pharm, 2009;6:295-304.
90. Javadzadeh Y, Hamedeyazdan S, Adibkia K, Kiafar F, Zarrintan MH, Barzegar-Jalali M. Evaluation of drug release kinetics and physico-chemical characteristics of metronidazole floating beads based on calcium silicate and gas-forming agents. Pharm Dev Techn, 2010;15:329-38.
91. Jeffery H, Davis SS, O'hagan DT. The preparation and characterization of poly(lactide-co-glycolide) microparticles: II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique. Pharm Res, 1993;10:362-8. (Pubitemid 23080599)
92. Joseph NJ, Lakshmi S, Jayakrishnan A. A floating type oral dosage form for piroxicam based on hollow polycarbonate microspheres: In-vitro and in-vivo evaluation in rabbits. J Control Release, 2002;79:71-9. (Pubitemid 34164162)
93. Kas HS. Chitosan: Properties, preparations and application to microparti-culate systems. J Microencapsul, 1997;14:689-711. (Pubitemid 27483088)
94. Kawashima Y, Lin SY, Kasai A, Handa T, Takenaka H. Preparation of a prolonged release tablet of aspirin with chitosan. Chem Pharm Bull (Tokyo), 1985;33:2107-13. (Pubitemid 15004727)
95. Kawashima Y, Niwa T, Takeuchi H, Hino T, Ito Y. Preparation of multiple unit hollow microspheres (microballoons) with acrylic resin containing tranilast and their drug release characteristics (in vitro) and floating behavior (in vivo). J Control Release, 1991;16:279-89.
96. Kawashima Y, Niwa T, Takeuchi H, Hino T, Itoh Y. Hollow microspheres for use as a floating controlled drug delivery system in the stomach. J Pharm Sci, 1992;81:135-40.
97. Khandai M, Chakraborty S, Sharma A, Pattnaik S, Patra CN, Dinda SC, Sen KK. Preparation and evaluation of algino-secrin mucoadhesive microspheres: An approach for sustained drug delivery. J Adv Pharmaceutical Res, 2010;1:48-60.
98. Khosla R, Davis SS. The effect of polycarbophil on the gastric emptying of pellets. J Pharm Pharmacol, 1987;39:47-9. (Pubitemid 17226692)
99. Khosla R, Feely LC, Davis SS. Gastrointestinal transit of non-disintegrating tablets in fed subjects. Int J Pharm, 1989;53:107-17.
100. Klausner EA, Eyal S, Lavy E, Friedman M, Hoffman A. Novel levodopa gastroretentive dosage form: In-vivo evaluation in dogs. J Control Release, 2003a;88: 117-26. (Pubitemid 36173957)
101. Klausner EA, Lavy E, Friedman M, Hoffman A. Expandable gastroretentive dosage forms. J Control Release, 2003b;90:143-62. (Pubitemid 36700451)
102. Klausner EA, Lavy E, Stepensky D, Friedman M, Hoffman A. Novel gastro-retentive dosage forms: Evaluation of gastroretentivity and its effect on riboflavin absorption in dogs. Pharm Res, 2002;19:1516-23. (Pubitemid 35266557)
103. Krogel I, Bodmeier R. Development of a multifunctional matrix drug delivery system surrounded by an impermeable cylinder. J Control Release, 1999;61:43-50. (Pubitemid 29406078)
104. Lachman L, Lieberman HA, Kanig JL, 1986. The theory and practice of industrial pharmacy. Philadelphia: Lea & Febiger; Beckenham: Quest-Meridien distributor.
105. Laheij ARJ, van Rossum LGM, Jansen JB, Straatman H, Verbeek AL. Evaluation of treatment regimens to cure Helicobacter pylori infections-A meta analysis. Aliment Pharmacol Ther, 1999;13:857-64. (Pubitemid 29312769)
106. Lee JH, Park TG, Choi HK. Development of oral drug delivery system using floating microspheres. J Microencapsul, 1999;16:715-29. (Pubitemid 29478951)
107. Lee JW, Park JH, Robinson JR. Bioadhesive-based dosage forms: The next generation. J Pharm Sci, 2000;89:850-66.
108. Lehr C-M, Boddé HE, Bouwstra JA, Junginger HE. A surface energy analysis of mucoadhesion: II. Prediction of mucoadhesive performance by spreading coefficients. Eur J Pharm Sci, 1993;1:19-30. (Pubitemid 24049931)
109. Lehr C-M, Bouwstra JA, Schacht EH, Junginger HE. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int J Pharm, 1992;78:43-8.
110. Lin HC, Elashoff JD, Gu Y-G, Meyer JH. Effect of meal volume on gastric emptying. Neurogastroenterol Motil, 1992;4:157-63.
111. Lis H, Sharon N. Lectins as molecules and as tools. Annu Res Biochem, 1986;55:35-67. (Pubitemid 16070763)
112. Liu L-S, Liu S-Q, Ng SY, Froix M, Ohno T, Heller J. Controlled release of interleukin-2 for tumour immunotherapy using alginate/chitosan porous microspheres. J Control Release, 1997;43:65-74. (Pubitemid 26393609)
113. Liu Z, Lu W, Qian L, Zhang X, Zeng P, Pan J. In vitro and in vivo studies on mucoadhesive microspheres of amoxicillin. J Control Release, 2005;102:135-44. (Pubitemid 40093780)
114. Lueben HL, Lehr CM, Rental CO, Noach ABJ, De boer AG, Verhoef JC, Junginger HE. Bioadhesive polymers for the peroraldelivery of peptide drugs. J Control Release, 1994;29:329-38. (Pubitemid 24156379)
115. Ma N, Xu L, Wang Q, Zhang X, Zhang W, Li Y, Jin L, Li S. Development and evaluation of new sustained-release floating microspheres. Int J Pharm, 2008;358:82-90.
116. Machida Y, Inouye K, Tokumura T, Iwata M, Nagai T. Preparation and evaluation of intragastric buoyant preparations. Drug Des Deliv, 1989;4:155-61. (Pubitemid 19076514)
117. Matharu RS, Sanghavi NM. Novel drug delivery system for captopril. Drug Dev Ind Pharm, 1992;18: 1567-74.
118. Mathiowitz E, Kreitz MR, Brannon-Peppas L, 1999. Microencapsulation. In: Mathiowitz E, editor. Encyclopedia of controlled drug delivery. New York: John Wiley & Sons.
119. McHugh DJ. 1987. Production, properties and uses of alginates. Food and Culture Organisation of the United Nations. Available at: http://www.fao.org/ docrep/X5822E/X5822E00.htm.
120. Menon A, Ritschel WA, Sakr A. Development and evaluation of a monolithic floating dosage form for furosemide. J Pharm Sci, 1994;83:239-45. (Pubitemid 24224185)
121. Miller LJ, Malagelada JR, Longstreth GF, Go VL. Dysfunctions of the stomach with gastric ulceration. Dig Dis Sci, 1980;25:857-64. (Pubitemid 11216919)
122. Mojaverian P, Vlasses PH, Kellner PE, Rocci ML. Effects of gender, posture, and age on gastric residence time of an indigestible solid: Pharmaceutical considerations. Pharm Res, 1988;5:639-44. (Pubitemid 18263610)
123. Montisci MJ, Dembri A, Giovannuci G, Chacun H, Duchene D, Ponchel G. Gastrointestinal transit and mucoadhesion of colloidal suspensions of Lycopersicon esculentum L. and Lotus tetragonolobus lectin-PLA micro-sphere conjugates in rats. Pharm Res, 2001;18:829-37. (Pubitemid 32783520)
124. Morimoto K, Yagamuchi H, Iwakura Y, Morisaka K, Ohashi Y, Nakai Y. Effects of viscous hyaluronate sodium solutions on the nasal absorption of vasopressin and an analogue. Pharm Res, 1991;8:471-4.
125. Murata Y, Sasaki N, Miyamoto E, Kawashima S. Use of floating alginate gel beads for stomach-specific drug delivery. Eur J Pharm Biopharm, 2000;50:221-6.
126. Nagahara N, Akiyama Y, Nakao M, Tada M, Kitano M, Ogawa Y. Mucoadhesive microspheres containing amoxicillin for clearance of Helicobacter pylori. Antimicrob Agents Chemother, 1998;42:2492-4. (Pubitemid 28462884)
127. Nagai T, Nishimoto Y, Nambu N, Suzuki Y, Sekine K. Powder dosage form of insulin for nasal administration. J Control Release, 1984;1: 15-22. (Pubitemid 15175635)
128. Naisbett B, John W. The potential use of tomato lectin for oral drug deliv-ery:3. Bioadhesion in vivo. Int J Pharm, 1995;114:227-36. (Pubitemid 24375905)
129. Nayak AK, Maji R, Das BK. Gastro retentive drug delivery systems: A review. J Pharm Clin Res, 2010;3 (1):2-3.
130. Nur AO, Zhang JS. Captopril floating and/or bioadhesive tablets: Design and release kinetics. Drug Dev Ind Pharm, 2000;26:965-9. (Pubitemid 30471042)
131. Obeidat WM, Price JC. Preparation and evaluation of Eudragit S 100 microspheres as pH-sensitive release preparations for piroxicam and theophylline using the emulsion-solvent evaporation method. J Microencapsul, 2006;23:195-202. (Pubitemid 43840670)
132. Ohya Y, Takei T, Kobayashi H, Ouchi T. Release behaviour of 5-fluorouracil from chitosan-gel microspheres immobilizing 5-fluorouracil derivative coated with polysaccharides and their cell specific recognition. J Microencapsul, 1993;10:1-9. (Pubitemid 23069809)
133. Oth M, Franz M, Timmermans J, Moes A. The bilayer floating capsule: A stomach-directed drug delivery system for misoprostol. Pharm Res, 1992;9:298-302.
134. Park K, Robinson JR. Bioadhesive polymers as platforms for oral-controlled drug delivery: Method to study bioadhesion. Int J Pharm, 1984;19: 107-27. (Pubitemid 14144031)
135. Park H, Robinson JR. Mechanisms of mucoadhesion of poly(acrylic acid) hydrogels. Pharm Res, 1987;4:457-64.
136. Patel GM. 2007. Floating drug delivery system: An innovative approach to prolong gastric retention. Available at: http://www.pharminfo.net. Accessed on 15 November 2010.
137. Patel JK, Chavda JR. Formulation and evaluation of stomach-specific amoxicillin-loaded carbopol-934P mucoadhesive microspheres for anti-Helicobacter pylori therapy. J Microencapsul, 2008;21:1-12.
138. Patel JK, Patel MM. Stomach specific anti-helicobacter pylori therapy: Preparation and evaluation of amoxicillin-loaded chitosan mucoadhe-sive microspheres. Curr Drug Deliv, 2007;4:41-50. (Pubitemid 46066413)
139. Patel YL, Sher P, Pawar AP. The effect of drug concentration and curing time on processing and properties of calcium alginate beads containing metronidazole by response surface methodology. AAPS PharmSciTech, 2006;7:86.
140. Pawar VK, Kansal S, Garg G, Awasthi R, Singodia D, Kulkarni GT. Gastroretentive dosage forms: A review with special emphasis on floating drug delivery systems. Drug Deliv, 2011;18:97-110. Epub 20 October 2010.
141. Peppas NA, Buri PA. Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues. J Control Release, 1985;2:257-75. (Pubitemid 16195943)
142. Ponchel G, Irache J. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv Drug Deliv Rev, 1998;34:191-219. (Pubitemid 28535112)
143. Quintanar-Guerrero D, Allémann E, Doelker E, Fessi H. Preparation and characterization of nanocapsules from preformed polymers by a new process based on emulsification-diffusion technique. Pharm Res, 1998a;15:1056-62. (Pubitemid 28356923)
144. Quintanar-Guerrero D, Allemann E, Fessi H, Doelker E. Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Dev Ind Pharm, 1998b;24: 1113-28. (Pubitemid 28546092)
145. Rajinikanth PS, Arunagaran LN, Balasubramaniam J, Mishra B. Formulation and evaluation of clarithromycin microspheres for eradication of Helicobacter pylori. Chem Pharm Bull, 2008;56:1658-64.
146. Rajinikanth PS, Mishra B. Stomach-site specific drug delivery system of clarithromycin for eradication of Helicobacter pylori. Chem Pharm Bull (Tokyo), 2009;57:1068-75.
147. Ramteke S, Umamaheshwari RB, Jain NK. Clarithromycin based oral sustained release nanoparticulate drug delivery system. Ind J Pharm Sci, 2006;68:479-84. (Pubitemid 44599821)
148. Reddy LH, Murthy RS. Floating dosage systems in drug delivery. Crit Rev Ther Drug Carrier Syst, 2002;19:553-85. (Pubitemid 36687722)
149. Rednick AB, Tucker SJ. 1970. Sustained release bolus for animal husbandry. United States patent application. 04/21/1970.
150. Rillosi M, Buckton G. Modelling mucoadhesion by use of surface energy terms obtained from the Lewis acid-Lewis base approach. II. Studies on anionic, cationic, and unionisable polymers. Pharm Res, 1995;12:669-75.
151. Robinson JR, Mlynek GM. Bioadhesive and phase-change polymers for ocular drug delivery. Adv Drug Del Rev, 1995;16:45-50.
152. Rocca JG, Omidian H, Shah K. Progresses in gastroretentive drug delivery systems. Business Briefing. Pharmatech 2003:152-6 Online. Available at: www.touchbriefings.com/pdf/17/ACF8D8E.pdf Accessed 16 October 2009.
153. Rouge N, Allemann E, Gex-Fabry M, Balant L, Cole ET, Buri P, Doelker E. Comparative pharmacokinetic study of a floating multiple-unit capsule, a high-density multiple-unit capsule and an immediate-release tablet containing 25 mg atenolol. Pharm Acta Helv, 1998;73:81-7. (Pubitemid 28327969)
154. Rouge N, Leroux J-C, Cole ET, Doelker E, Buri P. Prevention of the sticking tendency of floating minitablets filled into hard gelatin capsules. Eur J Pharm Biopharm, 1997;43:165-71. (Pubitemid 28298797)
155. Rubinstein A, Friend DR, 1994. Specific delivery to the gastrointestinal tract. In: Domb AJ, editor. Polymeric site-specific. Pharmacotherapy. Chichester: Wiley 267-313.
156. Sahasathian T, Praphairaksit N, Muangsin N. Mucoadhesive and floating chitosan-coated alginate beads for the controlled gastric release of amoxicillin. Arch Pharma Res, 2010;33:889-99.
157. Säkkinen M, Marvola J, Kanerva H, Lindevall K, Ahonen A, Marvola M. Are chitosan formulations mucoadhesive in the human small intestine?: An evaluation based on gamma scintigraphy. Int J Pharm, 2006;307:285-91. (Pubitemid 41820426)
158. Sakr FM. A programmable drug delivery system for oral administration. Int J Pharm, 1999;184:131-9. (Pubitemid 29309003)
159. Sanford PA, Baird J, 1983. Industrial utilization of polysaccharides. In: Aspinall GO, editor. The polysaccharides. New York: Academic. pp 411-90.
160. Sato Y, Kawashima Y, Takeuchi H, Yamamoto H. In-vivo evaluation of riboflavin-containing microballoons for a controlled drug delivery system in healthy human volunteers. J Control Release, 2003;93: 39-47. (Pubitemid 37346267)
161. Sato Y, Kawashima Y, Takeuchi H, Yamamoto H. In vitro and in vivo evaluation of riboflavin containing microballoons for a controlled drug delivery system in healthy humans. Int J Pharm, 2004;275:97-107. (Pubitemid 38481523)
162. Schnurrer J, Lehr C-M. Mucoadhesive properties of the mussel adhesive protein. Int J Pharm, 1996;141:251-6. (Pubitemid 26302930)
163. Scholes S, 1998. Production technique for biodegradable microspheres. In: Park K, editor. Controlled drug delivery: Challenge and strategies. New York: American Chemical Society Press.
164. Sheth PR, Tossounian JL. 1979. Novel sustained release tablet formulations. US patent application US Patent 4167558. September 11.
165. TM): A novel drug delivery system for oral use. Drug Dev Ind Pharm, 1984;10:313-39. (Pubitemid 14137879)
166. Singh BN, Kim KH. Floating drug delivery systems: An approach to oral controlled drug delivery via gastric retention. J Control Release, 2000;63:235-59.
167. Singh J, Robinson DH. Controlled release captopril microcapsules: Effect of non-ionic surfactants on release from ethyl cellulose microcapsules. J Microencapsul, 1988;5:129-37.
168. Singh B, Sharma V, Chauhan D. Gastroretentive floating sterculia-alginate beads for use in antiulcer drug delivery. Chem Eng Res Des, 2010;88:997-1012.
169. Singla AK, Chawla M. Chitosan: Some pharmaceutical and biological aspects-An update. J Pharm Pharmacol, 2001;53:1047-67. (Pubitemid 32754936)
170. Singla AK, Chawla M, Singh A. Potential applications of carbomer in oral mucoadhesive controlled drug delivery system: A review. Drug Dev Ind Pharm, 2000;26:913-24. (Pubitemid 30471037)
171. Smart JD. The basics and underlying mechanisms of mucoadhesion. Adv Drug Deliv Rev, 2005;57:1556-68. (Pubitemid 41443469)
172. Smart JD, Kellaway IW, Worthington HE. An in-vitro investigation of mucosa-adhesive materials for use in controlled drug delivery. J Pharm Pharmacol, 1984;36:295-9. (Pubitemid 14101358)
173. Soppimath KS, Aminabhavi TM, Agnihotri SA, Mallikarjuna NN, Kulkarni PV. Effect of coexcipients on drug release and floating property of nifedipine hollow microspheres: A novel gastro retentive drug delivery system. J Applied Polym Sci, 2006;100:486-94.
174. Soppimath KS, Kulkarni AR, Rudzinski WE, Aminabhavi TM. Microspheres as floating drug-delivery systems to increase gastric retention of drugs. Drug Metab Rev, 2001;33:149-60. (Pubitemid 32703254)
175. Sriamornsak P, Thirawong N, Puttipipatkhachorn S. Morphology and buoyancy of oil-entrapped calcium pectinate gel beads. AAPS, 2004;J6:e24.
176. Srivastava AK, Ridhurkar DN, Wadhwa S. Floating microspheres of cime-tidine: Formulation, characterization and in vitro evaluation. Acta Pharm, 2005;55:277-85. (Pubitemid 41495271)
177. Stockert RJ, Morell AG. Hepatic binding protein: The galactose-specific receptor of mammalian hepatocytes. Hepatol, 1983;3:750-7. (Pubitemid 13007704)
178. Stockwell AF, Davis SS, Walker SE. In vitro evaluation of alginate gel systems as sustained release drug delivery systems. J Control Release, 1986;3:167-75. (Pubitemid 16168147)
179. Streubel A, Siepmann J, Bodmeier R. Floating microparticles based on low density foam powder. Int J Pharm, 2002;241:279-92. (Pubitemid 34718029)
180. Streubel A, Siepmann J, Bodmeier R. Multiple unit gastroretentive drug delivery systems: A new preparation method for low density micropar-ticles. J Microencapsul, 2003;20:329-47. (Pubitemid 36621475)
181. Streubel A, Siepmann J, Bodmeier R. Drug delivery to the upper small intestine window using gastroretentive technologies. Curr Opin Pharmacol, 2006;6:501-8. (Pubitemid 44340666)
182. Sultana S, Bhavna, Iqbal Z, Panda BP, Talegaonkar S, Bhatnagar A, Ahmad FJ. Lacidipine encapsulated gastroretentive microspheres prepared by chemical denaturation for Pylorospasm. J Microencapsul, 2009;26:385-93.
183. Sungthongjeen S, Paeratakul O, Limmatvapirat S, Puttipipatkhachorn S. Preparation and in vitro evaluation of a multiple-unit floating drug delivery system based on gas formation technique. Int J Pharm, 2006;324:136-43. (Pubitemid 44528911)
184. Swarbrick J, Baylan JC, 1994. Enclyclopedia of pharmaceutical technology. New York: Marcel Dekker.
185. Tanwar YS, Naruka PS, Ojha GR. Development and evaluation of floating microspheres of verapamil hydrochloride. Brazilian J Pharm Sci, 2007;43:529-34. (Pubitemid 351517855)
186. Timmermans J, Moes AJ. Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: New data for reconsidering the controversy. J Pharm Sci, 1994;83:18-24. (Pubitemid 24233723)
187. Umamaheshwari RB, Jain NK. Receptor mediated targeting of lectin conjugated gliadin nanoparticles in the treatment of Helicobacter pylori. J Drug Target, 2003;11:415-23; discussion 423-4.
188. Umamaheshwari RB, Jain S, Bhadra D, Jain NK. Floating microspheres bearing acetohydroxamic acid for the treatment of Helicobacter pylori. J Pharm Pharmacol, 2003;55:1607-13. (Pubitemid 38054390)
189. Umamaheswari RB, Jain S, Tripathi PK, Agrawal GP, Jain NK. Floating-bioadhesive microspheres containing acetohydroxamic acid for clearance of Helicobacter pylori. Drug Deliv, 2002;9:223-31. (Pubitemid 35397024)
190. Umezawa H. 1978. Pepstatin floating minicapsules. United States patent application 05/785268.
191. Urguhart J, Theeuwes F. 1994. Drug delivery system comprising a reservoir containing a plurality of tiny pills. United States patent application.
192. Vaiciunas S, Oliveira MA, Bezerra IL, Oliveira EG, Souza CM, Loiola CFN. M1137 floating-bioadhesive microspheres of clarithromycin versus antibacterial agent ceragenin CsA-13 for eradication of helicobacter pylori resistant: Meta-analysis. Gastroenterol, 2010;138:S-339-S-340.
193. van Gansbeke B, Timmermans J, Schoutens A, Moës A. Intragastric positioning of two concurrently ingested pharmaceutical matrix dosage forms. Int J Radiation App Instrumentation. Part B. Nucl Med Biol, 1991;18:711-3715-8.
194. Vandegaer JE, 1974. Microencapsulation: Processes and applications. New York, London: Plenum.
195. Vasir JK, Tambwekar K, Garg S. Bioadhesive microspheres as a controlled drug delivery system. Int J Pharm, 2003;255:13-32. (Pubitemid 36369587)
196. Vyas SP, Khar RK, 2006. Gastroretentive systems. In: Vyas SP, Khar RK, editors. Controlled drug delivery concepts and advances. India: Vallabh Prakashan, Delhi. pp 197-217.
197. Wang J, Tauchi Y, Deguchi Y, Morimoto K, Tabata Y, Ikada Y. Positively charged gelatin microspheres as gastric mucoadhesive drug delivery system for eradication of H. pylori. Drug Deliv, 2000;7:237-43. (Pubitemid 32057556)
198. Washington N, Washington C, Wilson CG, 2001. Physiological pharmaceutics: Barriers to drug absorption. 2nd ed. London: Taylor & Francis.
199. Waugh A, Grant A, Ross JS, 2001. Ross and Wilson: Anatomy and physiology in health and illness. 9th ed. Edinburgh: Churchill Livingstone.
200. Whitehead L, Collett JH, Fell JT. Amoxycillin release from a floating dosage form based on alginates. Int J Pharm, 2000;210:45-9. (Pubitemid 32332640)
201. Whitehead L, Fell JT, Collett JH, Sharma HL, Smith A. Floating dosage forms: An in vivo study demonstrating prolonged gastric retention. J Control Release, 1998;55:3-12. (Pubitemid 28477559)
202. Woo BH, Jiang G, Jo YW, Deluca PP. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery. Pharm Res, 2001;18:1600-6. (Pubitemid 33022417)
203. Yang L, Eshraghi J, Fassihi R. A new intragastric delivery system for the treatment of Helicobacter pylori associated gastric ulcer: In vitro evaluation. J Control Release, 1999;57:215-22. (Pubitemid 29073437)
204. Yassin AEB, Alsarra IA, Al-Mohizea AM. 2006. Chitosan beads as a new gastroretentive system of verapamil. Wien, AUTRICHE: Sterreichische Apotheker-Verlagsgesellschaft.
205. Yellanki SK, Singh J, Syed JA, Bigala R, Goranti S, Nerella NK. Design and characterization of amoxicillin trihydrate mucoadhesive micro-spheres for prolonged gastric retention. Int J PharmSci Drug Res, 2010;2:112-14.
206. Yuasa H, Takashima Y, Kanaya Y. Studies on the development of intra-gastric floating and sustained release preparation: I. Application of calcium silicate as a floating carrier. Chem Pharm Bull, 1996;44: 1361-6. (Pubitemid 26256509)
207. Zheng J, Liu C, Bao D, Zhao Y, Ma X. Preparation and evaluation of floating-bioadhesive microparticles containing clarithromycin for the eradication of Helicobacter pylori. J Appl Polym Sci, 2006;102:2226-32. (Pubitemid 44619596)